Cross Cancer Institute /ID# 203114

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling